Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.520
+0.220 (6.67%)
At close: Oct 20, 2025, 4:00 PM EDT
3.546
+0.026 (0.74%)
After-hours: Oct 20, 2025, 6:25 PM EDT
MRVI Revenue
Maravai LifeSciences Holdings had revenue of $47.40M in the quarter ending June 30, 2025, a decrease of -31.73%. This brings the company's revenue in the last twelve months to $219.83M, down -19.95% year-over-year. In the year 2024, Maravai LifeSciences Holdings had annual revenue of $259.19M, down -10.30%.
Revenue (ttm)
$219.83M
Revenue Growth
-19.95%
P/S Ratio
2.14
Revenue / Employee
$385,667
Employees
570
Market Cap
898.87M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 259.19M | -29.76M | -10.30% |
Dec 31, 2023 | 288.95M | -594.06M | -67.28% |
Dec 31, 2022 | 883.00M | 83.76M | 10.48% |
Dec 31, 2021 | 799.24M | 515.14M | 181.33% |
Dec 31, 2020 | 284.10M | 140.96M | 98.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
MRVI News
- 2 months ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Maravai LifeSciences Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 - GlobeNewsWire
- 3 months ago - Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences - GlobeNewsWire
- 4 months ago - Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer - GlobeNewsWire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - Accesswire